Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INDIA GLOBALIZATION CAPITAL, INC.

(IGC)
Delayed Nyse  -  04:00 2022-10-04 pm EDT
0.4504 USD   +1.35%
09/21IGC Announces Issuance of Second Patent for the Treatment of Alzheimer's Using THC
BU
09/12IGC Announces Results of its 2022 Annual Stockholders Meeting
BU
09/09India Globalization Capital, Inc. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Business Summary
Logo India Globalization Capital, Inc.
India Globalization Capital, Inc. (IGC) is engaged in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment includes the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment includes construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer. It is also focused on developing Naphthalene Monoimide (NMI) lead candidate, IGC-AD1, that targets neuropsychiatric symptoms associated with dementia in Alzheimer’s.

Number of employees : 52 people.
Sales per Business
20212022Delta
Life Sciences0.7280.5%0.3690.7% -50.35%
Infrastructure0.1819.5%0.049.3% -78.86%
USD in Million
Sales per region
20212022Delta
United States--0.3382.9%-
India0.1819.5%0.0717.1% -61.14%
USD in Million
Managers
Name Title Age Since
Ram Mukunda President, Chief Executive Officer & Director 62 -
Claudia Grimaldi CFO, Director, Chief Compliance Officer & VP 50 2022
Jagadeesh Rao, Dr. Chief Scientific Officer 54 2017
Rohit Goel Chief Accounting Officer 27 -
Members of the board
Name Title Age Since
Richard K. Prins Chairman 64 -
John E. Lynch Independent Director 83 2021
James Patrick Moran Independent Director 77 2022
Ram Mukunda President, Chief Executive Officer & Director 62 -
Claudia Grimaldi CFO, Director, Chief Compliance Officer & VP 50 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,534,353 43,444,705 82.7% 0 0.0% 82.7%
Shareholders
NameEquities%
Ram Mukunda 4,052,178 7.71%
Global X Management Co. LLC 1,127,270 2.15%
Richard K. Prins 755,000 1.44%
BlackRock Fund Advisors 706,242 1.34%
The Vanguard Group, Inc. 629,478 1.20%
Claudia Grimaldi 558,821 1.06%
Carroll Financial Associates, Inc. 320,000 0.61%
Geode Capital Management LLC 302,884 0.58%
John E. Lynch 284,401 0.54%
Virtu Americas LLC 281,304 0.54%
Brand Portfolio
In partnership withAllbrands.markets
More brands of India Globalization Capital, Inc.
Connections : India Globalization Capital, Inc.